Xiaoqin An
-
- Pregnancy and preeclampsia studies 1
-
- RNA modifications and cancer 2
-
- Lung Cancer Research Studies 3
- CAR-T cell therapy research 1
-
- Lung Cancer Treatments and Mutations 3
- Ferroptosis and cancer prognosis 2
-
- Neuroendocrine Tumor Research Advances 1
-
- Childhood Cancer Survivors' Quality of Life 1
- Co-authors
- Daolin TangJinbao LiuYang LiWenfeng YuXin ChenDongmei FanYingchun YuMeimei Shi
- Journals
- Journal of Clinical Oncology (1 paper)Frontiers in Immunology (1 paper)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoqin An
10 papers receiving 270 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 32
- Toxicology 7
- Obstetrics and Gynecology 13
- Molecular Biology 109
- Geriatrics and Gerontology 6
Countries citing papers authored by Xiaoqin An
This map shows the geographic impact of Xiaoqin An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqin An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqin An more than expected).
Fields of papers citing papers by Xiaoqin An
This network shows the impact of papers produced by Xiaoqin An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqin An. The network helps show where Xiaoqin An may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoqin An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | Oxidative cell death in cancer: mechanisms and therapeutic opportunitiesbreakdown → | 2024 | 204 |
| 7 | 2023 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 0 | |
| 12 | 2018 | 36 |
About Xiaoqin An
Xiaoqin An is a scholar working on Molecular Medicine, Oncology and Microbiology, having authored 12 papers that have together received 274 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Ferroptosis and cancer prognosis (2 papers), RNA modifications and cancer (2 papers), Pregnancy and preeclampsia studies (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (32 citations), Toxicology (7 citations) and Obstetrics and Gynecology (13 citations). Xiaoqin An has collaborated with scholars based in China and United States. Frequent co-authors include Daolin Tang, Jinbao Liu, Yang Li, Wenfeng Yu, Xin Chen, Dongmei Fan, Yingchun Yu, Meimei Shi, Siqi Sun and Hanyu Wang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.